Subscribe To
EIGR / Eiger Biopharmaceuticals: Value Inflection For Lead Asset In HDV Infection On The Horizon
Content Topics
Eiger
Biopharmaceuticals
Value
Inflection
Lead
Asset
Biopharmaceuticals
Infection
Horizon
Stock
EIGR
EIGR News
By InvestorPlace
September 13, 2023
Why Is Eiger BioPharmaceuticals (EIGR) Stock Down 31% Today?
Eiger BioPharmaceuticals (NASDAQ: EIGR ) stock is falling on Wednesday after the biopharmaceutical company halted a Phase 3 clinical trial. According more_horizontal
By Seeking Alpha
June 16, 2023
Eiger BioPharmaceuticals: Wall Street Has High Expectations For Faltering Battleground Stock
Wall Street Analysts have high expectations for Eiger. Eiger has a modest pipeline. Expect near term data to impact the stock in a big way. more_horizontal
By Pulse2
February 9, 2023
EIGR Stock: 23.53% Surge Explanation
The stock price of Eiger BioPharmaceuticals Inc. (Nasdaq: EIGR) surged by 23.53% today. This is why. more_horizontal
By PRNewsWire
December 7, 2022
Eiger BioPharmaceuticals to Host Conference Call to Discuss Phase 3 D-LIVR Study Results of Lonafarnib-based Treatments in Hepatitis Delta Virus (HDV) on Thursday, December 8, 2022
Live Conference Call and Webcast at 8:30 AM ET PALO ALTO, Calif. , Dec. 7, 2022 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a comm more_horizontal
By Seeking Alpha
November 26, 2022
Eiger BioPharmaceuticals: A Compelling High Beta Story
Today, we revisit the investment case around Eiger BioPharmaceuticals for the first time in more than a year and a half. Eiger has one product on the more_horizontal
By Seeking Alpha
November 3, 2022
Eiger BioPharmaceuticals, Inc. (EIGR) Q3 2022 Earnings Call Transcript
Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR ) Q3 2022 Results Conference Call November 3, 2022 4:30 PM ET Company Participants Sarah Mathieson - Senio more_horizontal
By Seeking Alpha
August 6, 2022
Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q2 2022 Results - Earnings Call Transcript
Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Sarah Mathieson - SVP, C more_horizontal
By Seeking Alpha
July 26, 2022
Eiger BioPharmaceuticals: Undervalued Biotech With End Of 2022 Catalyst
European Commission granted marketing authorization for Zokinvy (lonafarnib) for the treatment of patients with progeria on July 20, 2022. Results fro more_horizontal